Top menu
Main menu
Main Content
The Shmunis School of Biomedicine and Cancer Research
The George S. Wise
Faculty of Life Sciences
Tel Aviv University
Home
MyTAU
Student Portal
Library
עברית
Search
This site
Global search
Vision
Faculty
Research
Awarded Scholars
Graduate School
Post Doc
Research Facilities
Contact Us
Donated Equipment Aids in Urgent Coronavirus Research
Shmunis family gift ramps up the scientific capabilities of the School of Molecular Cell Biology and Biotechnology
Apr 6th, 2020
Donated Equipment Aids in Urgent Coronavirus Research
You are here
The Shmunis School of Biomedicine and Cancer Research
>
The Shmunis School of Biomedicine and Cancer Research
> News
Fields:
Select all
Life Sciences
Social Sciences
Categories:
Select all
Event
Events
Innovations
Award
Honors
NEWS
What are you interested in?
All topics
שיוך לתחומים (field_research_zone)
שיוך לתחומים (field_news_belong_area)
Life Sciences
Social Sciences
שיוך לתחומים חדש (field_belong_domains)
- Any -
Nov 15th, 2022
Newly funded Twinning project on protein biophysics
This project is funded by the European Union (EU) in the amount of €1,228,957
Life Sciences
Life Sciences
Sep 21st, 2022
2022 Shmunis School Retreat
During the event that occurred in July, the various units of the school presented new activities in their research fields, including genetics, cancer research, biochemistry, microbiology, bioinformatics, cell biology
Sep 4th, 2022
New method eradicates deadly brain tumors by ‘starving’ them of energy source
The researchers: "These findings provide a promising basis for developing effective medications for glioblastoma, an aggressive, and thus far incurable cancer, as well as other types of brain tumors."
Life Sciences
Life Sciences
Mar 30th, 2022
Four Shmunis researchers are among the rector’s list for excellent teaching
The list includes only 20 faculty members from all over the university
Mar 13th, 2022
Prof. Ehud Gazit – the first Israeli to receive a prestigious international
Prof. Ehud Gazit from the Shmunis School of Biomedicine and Cancer Research at the Wise Faculty of Life Sciences and the Department of Materials Science at the Fleischman Faculty of Engineering, was selected as the International Solvay Chair in Chemistry for 2023
Mar 6th, 2022
Novel technology could prevent repeat operations to replace a faulty
This technological development stems from the EU-funded TRANSLINK consortium consisting of 14 members from Europe, USA and Canada and led by Dr. Vered Padler-Karavani from The Shmunis School of Biomedicine and Cancer Research at Tel Aviv University
Feb 24th, 2022
Prof. Anat Herskovits – Member of the European Academy of Microbiology
Prof. Anat Herskovits, vice head of the Shmunis School of Biomedicine and Cancer Research and the current president of the Israeli Society of Microbiology , was appointed as a member of the European Academy of Microbiology (EAM)
Jan 26th, 2022
Scientific breakthrough may enable people with paralysis to walk again
In world first, Tel Aviv University researchers engineer human spinal cord implants for treating paralysis
Jan 20th, 2022
Dr. Aldema Sas-Chen won the Eclipse Award for Innovation in High Throughput
The award is granted by the RNA Society and is sponsored by Eclipse BioInnovations, a leading commercial genomics company based in San Diego, California
Jan 10th, 2022
Viruses and Game Theory
A new study from Tel Aviv University has found that, just like humans with Game Theory, viruses called bacteriophages (or phages) weigh all options and finally make an informed decision - whether the time has come to exit the dormant state and attack their bacterial host
Oct 20th, 2021
An Open Faculty Position: the Shmunis School of Biomedicine and Cancer Research
The Shmunis School of Biomedicine and Cancer Research seeks excellent candidates for a tenure-track faculty position. The position will start either in July or October 2022
Show More
Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing,
Contact us as soon as possible >>